Andrew Pusar, an associate in Goodwin’s Technology Companies and Life Sciences group, concentrates in general corporate and securities law and has significant experience in capital markets transactions, mergers and acquisitions, venture capital financings, SEC compliance and corporate governance. Mr. Pusar represents public and private emerging growth technology and life science companies as well as venture capital funds and investment banks focusing on technology and life science companies. He has experience advising companies through every stage of the corporate life cycle – from initial financing through successful initial public offering or acquisition.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. Pusar’s transactional experience includes the following venture capital financings, capital markets transactions and mergers and acquisitions:

Venture Financings

  • Kensho Technologies in its Series B financing with participation by S&P, Goldman Sachs, General Catalyst, Morgan Stanley, Bank of America and JPMorgan
  • Codiak BioSciences in its Series C financing with participation by ARCH Venture Partners, Flagship Pioneering and Fidelity Management and Research Company
  • Glossier in its Series B financing led by Institutional Venture Partners, with participation from Index Ventures, Thrive Capital and Forerunner Ventures
  • Anchor FM in its Series A financing led by Google Ventures and Accel
  • Precision Biologics in its Series A financing by an affiliate of NantWorks
  • Orchard Platform in its Series B financing led by Thrive Capital, Spark Capital and Canaan Partners
  • Even Financial in its Series A financing with participation by GreatPoint Ventures, Goldman Sachs PSI, Canaan Partners, Fidelity, Lerer Hippeau and AMEX

Capital Markets

  • CRISPR Therapeutics AG in its initial public offering
  • Represented the underwriters, including RBC, in Altair Engineering’s initial public offering and follow-on offering
  • Represented investment bankers, including Cowen, in G1 Therapeutics’ initial public offering and follow-on offering
  • Represented William Blair in follow-on offerings by USA Technologies
  • Represented Cowen in follow-on offerings by Albireo Pharma
  • Represented the underwriter in Oncobiologics’ initial public offering
  • Represented the underwriters in a follow-on offering by Syndax Pharmaceuticals
  • Represented Cowen and Company in multiple “At-the-Market” transactions

Mergers and Acquisitions

  • Kensho Technologies in its sale to S&P Global
  • Interactions in its acquisition of Digital Roots
  • Orchard Platform in its sale of substantially all of its assets to Kabbage, Inc.
  • Nalari Health in its sale to BehaveCare
  • Catheter Connections in its sale to Merit Medical Systems
Professional Activities

Mr. Pusar is a frequent lecturer at Columbia Business School and Columbia Law School on venture financings and other elements of start-up law. He also holds office hours for emerging companies working with the New York Angels, which is one of the longest-running active angel groups in New York City. Mr. Pusar is also an active leader at Goodwin, committed to global initiatives supporting practice management, and associate development efforts rooted in the firm’s core values. He frequently participates in Goodwin’s recruiting, training and mentoring efforts which focus on the importance of Diversity & Inclusion.

Professional Experience

Prior to joining Goodwin, Mr. Pusar was an associate in the New York office of Davis Polk & Wardwell LLP.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2012
Columbia Law School

(Harlan Fiske Stone scholar)

B.A., 2009
Harvard University

Admissions

Bar

New York
New Jersey
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师